The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
Open accessAbstract
Neurodegenerative diseases including Alzheimer (AD) and Parkinson (PD) have attracted attention in last decades due to their high incidence worldwide. The etiology of these diseases is still unclear; however the role of the environment as a putative risk factor has gained importance. More worryingly is the evidence that pre- and post-natal exposures to environmental factors predispose to the onset of neurodegenerative diseases in later life. Neurotoxic metals such as lead, mercury, aluminum, cadmium and arsenic, as well as some pesticides and metal-based nanoparticles have been involved in AD due to their ability to increase beta-amyloid (Aβ) peptide and the phosphorylation of Tau protein (P-Tau), causing senile/amyloid plaques and neurofibrillary tangles (NFTs) characteristic of AD. The exposure to lead, manganese, solvents and some pesticides has been related to hallmarks of PD such as mitochondrial dysfunction, alterations in metal homeostasis and aggregation of proteins such as α-synuclein (α-syn), which is a key constituent of Lewy bodies (LB), a crucial factor in PD pathogenesis. Common mechanisms of environmental pollutants to increase Aβ, P-Tau, α-syn and neuronal death have been reported, including the oxidative stress mainly involved in the increase of Aβ and α-syn, and the reduced activity/protein levels of Aβ degrading enzyme (IDE)s such as neprilysin or insulin IDE. In addition, epigenetic mechanisms by maternal nutrient supplementation and exposure to heavy metals and pesticides have been proposed to lead phenotypic diversity and susceptibility to neurodegenerative diseases. This review discusses data from epidemiological and experimental studies about the role of environmental factors in the development of idiopathic AD and PD, and their mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“The amyloid cascade hypothesis establishes that Aβ aggregation initiates the brain damage leading to memory loss and to AD (Hardy and Higgins, 1992).”
BackgroundDNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 3×
“The motor symptoms appear when at least 60% of dopaminergic neurons are lost and 80–85% of dopamine content in the striatum is depleted (Jankovic, 2008; Wirdefeldt et al., 2011).”
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Oxidative mechanisms in the toxicity of metal ions
Stohs, S. J., & Bagchi, D. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00159-h · Cited by 4,219 · cited 2×
“Tokimasa, M., Minoura, K., Hiraoka, S., Tomoo, K., Sumida, M., Taniguchi, T., et al. (2005). Importance of local structures of second and third repeat fragments of microtubule-binding domain for tau filament formation.”
BackgroundGauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
Leski, S., Lindén, H., Tetzlaff, T., Pettersen, K. H., & Einevoll, G. T. (2013) · PubMed · doi:10.18154/rwth-conv-084442 · Cited by 3,639
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Research works printed but not linked: 15
- Bergen, 1971, The in vitro effect of dieldrin on respiration of rat liver mitochondria, Proc. Soc. Exp. Biol. Med., 136, 732, 10.3181/00379727-136-35352 · doi:10.3181/00379727-136-35352
- Couper, 1837, On the effects of black oxide of manganese when inhaled into the lungs, Br. Ann. Med. Pharmacol., 1, 41
- Harischandra, 2015, α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson’s disease, Toxicol. Sci., 143, 454, 10.1093/toxsci/kfu247 · doi:10.1093/toxsci/kfu247
- Kala, 1995, Low level lead exposure decreases in vivo release of dopamine in the rat nucleus accumbens: a microdialysis study, J. Neurochem., 65, 1631, 10.1046/j.1471-4159.1995.65041631.x · doi:10.1046/j.1471-4159.1995.65041631.x
- Kochen, 2003, The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson’s disease, Adv. Exp. Med. Biol., 527, 253, 10.1007/978-1-4615-0135-0_29 · doi:10.1007/978-1-4615-0135-0_29
- Li, 2014a, The effects of early life Pb exposure on the expression of IL1-beta, TNF-alpha and Abeta in cerebral cortex of mouse pups, J. Trace Elem. Med. Biol., 28, 100, 10.1016/j.jtemb.2013.07.003 · doi:10.1016/j.jtemb.2013.07.003
- Liu, 2014, Effects of lead exposure on the expression of amyloid beta and phosphorylated tau proteins in the C57BL/6 mouse hippocampus at different life stages, J. Trace Elem. Med. Biol., 28, 227, 10.1016/j.jtemb.2014.01.002 · DOI
- Lu, 1994, Levodopa failure in chronic manganism, Neurology, 44, 1600, 10.1212/wnl.44.9.1600 · doi:10.1212/wnl.44.9.1600
- Papageorgiou, 2009, Severe dopaminergic pathways damage in a case of chronic toluene abuse, Clin. Neurol. Neurosurg., 111, 864, 10.1016/j.clineuro.2009.07.007 · doi:10.1016/j.clineuro.2009.07.007
- Pezzoli, 1989, Parkinsonism due to n-hexane exposure, Lancet, 2, 874, 10.1016/s0140-6736(89)93050-x · doi:10.1016/s0140-6736(89)93050-x
- Pezzoli, 1990, n-hexane induces parkinsonism in rodents, Brain Res., 531, 355, 10.1016/0006-8993(90)90801-h · doi:10.1016/0006-8993(90)90801-h
- Purkerson-Parker, 2001, Dopamine transporter binding in the rat striatum is increased by gestational, perinatal and adolescent exposure to heptachlor, Toxicol. Sci., 64, 216, 10.1093/toxsci/64.2.216 · doi:10.1093/toxsci/64.2.216
- Singer, 1997, Tau in aluminum-induced neurofibrillary tangles, Neurotoxicology, 18, 63
- Tokimasa, 2005, Importance of local structures of second and third repeat fragments of microtubule-binding domain for tau filament formation, FEBS Lett., 579, 3481, 10.1016/j.febslet.2005.05.020 · doi:10.1016/j.febslet.2005.05.020
- Wagner, 1978, Dieldrin-induced alterations in biogenic amine content of rat brain, Toxicol. Appl. Pharmacol., 43, 45, 10.1016/s0041-008x(78)80031-3 · doi:10.1016/s0041-008x(78)80031-3
Cited by
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,254
The effects of heavy metals on human metabolism
Fu, Z., & Xi, S. (2020) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2019.1701594 · Cited by 1,025
The role of interleukin-6 signaling in nervous tissue
Rothaug, M., Becker-Pauly, C., & Rose-John, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.018 · Cited by 491
The toxicology of mercury: Current research and emerging trends
Bjørklund, G., Dadar, M., Mutter, J., & Aaseth, J. (2017) · Environmental Research · doi:10.1016/j.envres.2017.08.051 · Cited by 482
Comunian, S., Dongo, D., Milani, C., & Palestini, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17124487 · Cited by 464
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases
Reichert, C. O., de Freitas, F. A., Sampaio-Silva, J., Rokita-Rosa, L., Barros, P. D. L., Levy, D., & Bydlowski, S. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228765 · Cited by 422
Neurodegenerative and neurological disorders by small inhaled particles
Heusinkveld, H. J., Wahle, T., Campbell, A., Westerink, R. H. S., Tran, L., Johnston, H., Stone, V., Cassee, F. R., & Schins, R. P. F. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.07.007 · Cited by 331
Pasluosta, C. F., Gassner, H., Winkler, J., Klucken, J., & Eskofier, B. M. (2015) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2015.2461555 · Cited by 323
“pollutants [9].”
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257
Street, M. E., Angelini, S., Bernasconi, S., Burgio, E., Cassio, A., Catellani, C., Cirillo, F., Deodati, A., Fabbrizi, E., Fanos, V., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061647 · Cited by 257
Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092313 · Cited by 240
Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics
Migliore, L., & Coppedè, F. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00714-w · Cited by 217
Microbiota-gut brain axis involvement in neuropsychiatric disorders
Iannone, L. F., Preda, A., Blottière, H. M., Clarke, G., Albani, D., Belcastro, V., Carotenuto, M., Cattaneo, A., Citraro, R., Ferraris, C., et al. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1638763 · Cited by 177
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170
Emerging risk of environmental factors: insight mechanisms of Alzheimer’s diseases.
Rahman, M. A., Rahman, M. S., Uddin, M. J., Mamum-Or-Rashid, A. N. M., Pang, M.-G., & Rhim, H. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-08243-z · Cited by 115
Inflammation as common link to progressive neurological diseases
Dias-Carvalho, A., Sá, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03628-8 · Cited by 60
Alquezar, C., Felix, J. B., McCandlish, E., Buckley, B. T., Caparros-Lefebvre, D., Karch, C. M., Golbe, L. I., & Kao, A. W. (2020) · Scientific Reports · doi:10.1038/s41598-019-56930-w · Cited by 49
Sharma, A., Goel, H., Sharma, S., Rathore, H. S., Jamir, I., Kumar, A., Thimmappa, S. C., Kesari, K. K., & Kashyap, B. K. (2024) · Environmental Science and Pollution Research · doi:10.1007/s11356-024-34977-1 · Cited by 34
Ahmed, S. S. S. J., Husain, R. S. A., Kumar, S., & Ramakrishnan, V. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.07.041 · Cited by 32
Progress and challenges in the diagnosis of dementia: a critical review
Paraskevaidi, M., Martin-Hirsch, P. L., & Martin, F. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00007 · Cited by 31
The Health-Promoting Effects and the Mechanism of Intermittent Fasting
Liu, S., Zeng, M., Wan, W., Huang, M., Li, X., Xie, Z., Wang, S., & Cai, Y. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4038546 · Cited by 27
Lutz, B. M., & Peng, J. (2018) · Proteomes · doi:10.3390/proteomes6040046 · Cited by 27
Semax prevents learning and memory inhibition by heavy metals
Inozemtsev, A. N., Bokieva, S. B., Karpukhina, O. V., Gumargalieva, K. Z., Kamensky, A. A., & Myasoedov, N. F. (2016) · Doklady Biological Sciences · doi:10.1134/s0012496616030066 · Cited by 3
Metadata
- Authors
- Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2015-04-10
- Volume
- 9
- Pages
- 124-124
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2034578928
- Cited by
- 707
- References
- 254
- FWCI
- 37.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.